Abstract
The concentration of circulating ferritin was measured in 250 normal adult women and 229 women presenting with early breast cancer. Ferritin concentrations are higher in cancer patients than in normal women. Patients with an intial circulating ferritin concentration above 200 mug/1 have a higher tumour recurrence rate during the subsequent 4 years.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Jacobs, A., Jones, B., Ricketts, C. et al. Serum ferritin concentration in early breast cancer. Br J Cancer 34, 286–290 (1976). https://doi.org/10.1038/bjc.1976.164
Issue Date:
DOI: https://doi.org/10.1038/bjc.1976.164
This article is cited by
-
A case–control study in Taiwanese cohort and meta-analysis of serum ferritin in pancreatic cancer
Scientific Reports (2021)
-
Targeting ferroptosis in breast cancer
Biomarker Research (2020)
-
Ferritin stimulates breast cancer cells through an iron-independent mechanism and is localized within tumor-associated macrophages
Breast Cancer Research and Treatment (2013)
-
Growth stimulation of ferritin of human leukemia cells in vitro
Journal of Cancer Research and Clinical Oncology (1995)
-
Relationship of serum and tumor levels of iron and iron-binding proteins to lymphocyte immunity against tumor antigen in breast cancer patients
Breast Cancer Research and Treatment (1994)
